Geisinger and Terumo Neuro Promote Stroke Awareness for World Stroke Day 2025

Advancing Stroke Education and Treatment: A Focus on World Stroke Day 2025

In celebration of World Stroke Day 2025, Geisinger and Terumo Neuro have joined forces to enhance public awareness around strokes and advocate for swift treatment methods. This collaboration highlights the significance of recognizing the early signs of a stroke, the urgency of accessing medical care, and the advancements in minimally invasive neurovascular treatments.

Raising Awareness

Every year, strokes claim lives and leave many individuals with long-term disabilities. Despite medical advancements, many remain unaware of the symptoms that denote a stroke. During this campaign, they will release an educational video featuring Dr. Oded Goren, a prominent figure at Geisinger Medical Center. He specializes in open vascular and endovascular neurosurgery. The video, entitled "Transforming Neurovascular Stroke Care: Geisinger and Physician Innovation in Action," aims to inform and inspire viewers about early interventions in stroke care.

Dr. Goren remarks, "Stroke is one of the leading causes of death globally, yet many people fail to identify its initial symptoms. At Geisinger, we strive to provide access to quality care, enhancing the survival rates of stroke patients. World Stroke Day allows us to educate the public and push for immediate action that can save lives."

Innovative Approaches to Treatment

One of the campaign's key focuses is on the advancements in hemorrhagic stroke treatments. Geisinger is utilizing cutting-edge technology like the WEB™ Embolization System that plays a crucial role in treating intricate brain aneurysms, thereby minimizing the risk of strokes. Such innovations not only enhance treatment efficacy but also ensure that patients have access to world-class care in proximity to their homes.

Many rural areas lack immediate access to stroke centers. Geisinger’s integrated care model helps address this void, demonstrating how community hospitals can facilitate advanced neurovascular interventions. Embarking on this initiative is significant as it establishes a framework to provide equitable healthcare, particularly in underserved regions.

Community Engagement and Education

As part of the campaign, Geisinger emphasizes the importance of recognizing stroke warning signs through the B.E.F.A.S.T. acronym — which stands for Balance, Eyes, Face drooping, Arm weakness, Speech difficulty, and Time to call 911. This straightforward method empowers communities to take decisive action promptly — a crucial step in improving stroke outcomes.

The campaign builds upon last year’s initiative that involved a partnership between Terumo Neuro and Tulane University School of Medicine, where they promoted fair access to healthcare and stroke education. This year, the spotlight is on Geisinger's leadership, strengthening the discourse on physician innovation and patient-centered care.

Collaborative Vision for Stroke Care

Carsten Schroeder, CEO of Terumo Neuro, expresses enthusiasm about the partnership: "We are thrilled to work alongside Geisinger and Dr. Goren in raising stroke awareness. Focusing on education and innovation is critical in revolutionizing stroke care while championing improved patient outcomes globally."

The collaboration not only signifies a commitment to addressing stroke care disparities but also demonstrates the melding of clinical expertise and innovative technology to redefine treatment pathways.

About Geisinger and Terumo Neuro

Founded in 1915, Geisinger has emerged as one of the leading healthcare systems in the country, serving approximately 1.2 million individuals across Pennsylvania. With a substantial revenue base and a robust infrastructure comprising numerous facilities, Geisinger is strategically positioned to lead initiatives such as this.

On the other hand, Terumo Neuro, established in 1997 and later acquired by Terumo Corporation, is dedicated to advancing neurovascular treatments, with an array of products available in more than seventy countries. Their continued commitment to innovation and patient care aligns seamlessly with Geisinger’s mission to provide equitable and high-quality healthcare solution.

For more information, visit Geisinger and Terumo Neuro. By taking these essential steps, Geisinger and Terumo Neuro aim to foster greater public understanding of strokes and ultimately save lives in the community.